FDA Peptide Review Could Ease Access, but Safety Questions Remain
Federal advisers have opened the door to temporary access for several unapproved peptide products, even as FDA warnings continue to stress that compounded versions are not reviewed for safety, effectiveness or quality.
FDA mifepristone review stretches into 2027 as debate continues
The FDA says its ongoing safety review of mifepristone will continue into next year, keeping one of the nation’s most closely watched drug-policy fights in motion.
FDA review of abortion pill safety will stretch into 2027
The FDA says its safety review of mifepristone will continue into next year, keeping attention on a drug that is widely used for abortion and miscarriage care.
FDA Links Cyclospora Outbreak to Mexican Lettuce Farm
Federal investigators say they found Cyclospora at a Mexican farm tied to a 2026 lettuce outbreak, adding clarity to a food safety probe that matters for older adults.